Search Results - "Hense, G."

  • Showing 1 - 20 results of 20
Refine Results
  1. 1

    High‐Altitude Climate Therapy Reduces Local Airway Inflammation and Modulates Lymphocyte Activation by Karagiannidis, C., Hense, G., Rueckert, B., Mantel, P. Y., Ichters, B., Blaser, K., Menz, G., Schmidt‐Weber, C. B.

    Published in Scandinavian journal of immunology (01-04-2006)
    “…High‐altitude climate therapy is a well‐established therapeutic option, which improves clinical symptoms in asthma. However, little is known about the…”
    Get full text
    Journal Article
  2. 2

    Distinct Leucocyte Redistribution After Glucocorticoid Treatment Among Difficult‐to‐Treat Asthmatic Patients by Karagiannidis, C., Rückert, B., Hense, G., Willer, G., Menz, G., Blaser, K., Schmidt‐Weber, C. B.

    Published in Scandinavian journal of immunology (01-02-2005)
    “…Difficult‐to‐treat asthma (DTA) represents a heterogeneous subgroup of asthma. Up to now, the lack of specific diagnosis not only complicates appropriate…”
    Get full text
    Journal Article
  3. 3

    Subpicosecond switch-off and switch-on of a semiconductor laser due to transient hot carrier effects by Elsässer, M., Hense, S. G., Wegener, M.

    Published in Applied physics letters (17-02-1997)
    “…Recently it has been shown that perturbation of an already operating semiconductor laser with an additional pump pulse may lead to an unusual ultrafast…”
    Get full text
    Journal Article
  4. 4

    Glucocorticoids upregulate FOXP3 expression and regulatory T cells in asthma by Karagiannidis, Christian, Akdis, Mübeccel, Holopainen, Päivi, Woolley, Niina J., Hense, Gabriele, Rückert, Beate, Mantel, Pierre-Yves, Menz, Günther, Akdis, Cezmi A., Blaser, Kurt, Schmidt-Weber, Carsten B.

    Published in Journal of allergy and clinical immunology (01-12-2004)
    “…T regulatory (Treg) cells are characterized by expression of suppressive cytokines and the transcription factor FOXP3. They play a key role in balancing immune…”
    Get full text
    Journal Article
  5. 5

    Afatinib in Non‐Small Cell Lung Cancer Harboring Uncommon EGFR Mutations Pretreated With Reversible EGFR Inhibitors by Schumann, Christian, Sebastian, Martin, Sadjadian, Parvis, Märten, Angela, Abdollahi, A., Aries, S.P., Arntzen, C., Atmaca, A., Basara, N., Borchard, B., Bos, M., Brugger, W., Budweiser, S., Corduan, K., Cortes‐Incio, D., Dallmeier, B., Denzlinger, C., Dittrich, I., Engel‐Riedel, W., Faehling, M., Fertl, A., Fischer, J.R., Fleckenstein, D., Folprecht, G., Forstbauer, A., France, Y., Frickhofen, N., Gardizi, M., Gauler, T., Gessner, C., Gökkurt, E., Görner, M., Grah, C., Greeve, J., Greiner, J., Grohé, C., Grüning, W., Guggenberger, D., Heinrich, B., Hense, G., Hoiczyk, M., Huber, R.M., Illerhaus, G., Jacobs, G., Jung, P., Kern, J., Kersten, J., Kiehl, M., Kisro, J., Knipp, H., Ko, Y.D., Koch, J.U., Koehne, C.H., Kollmeier, J., Kommer, A., Körber, W., Krause, G., Krügel, R., Leistner, R., Liebers, U., Lommatzsch, M., Maintz, C., Mohr, M., Neumeister, W., Overbeck, T., Panse, J., Pelzer, T., Peters, K., Planker, M., Reissig, A., Ritter, M., Sadjadian, P., Sandritter, B., Schatz, M., Scheffler, M., Schmid‐Bindert, G., Schneider, C.P., Schneider‐Kappus, W., Schreiber, J., Schütte, W., Schütz, S., Sebastian, M., Serke, M., Staiger, H., Stehle, I., Stengele, K., Stöhlmacher‐Williams, J., Strapatsas, T., Sulzbach, B., Tessmer, A., Thomas, M., Ukena, D., Wagner, B., Wagner‐Hug, D., Witt, C., Wohlleber, M., Wolf, J., Wricke, K., Zaba, O., Zander, I.

    Published in The oncologist (Dayton, Ohio) (01-10-2015)
    “…Background. Afatinib, an irreversible ErbB family blocker, is approved for treatment of patients with previously untreated non‐small cell lung cancer (NSCLC)…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Unusual picosecond dynamics of a semiconductor vertical-cavity-surface-emitting laser under resonant perturbation by Hense, S. G., Wegener, M.

    Published in Applied physics letters (15-02-1999)
    “…A stationary electrically pumped semiconductor vertical cavity surface emitting laser held at T=300 K is perturbed by a femtosecond optical pulse, which is…”
    Get full text
    Journal Article
  8. 8

    Allergic bronchopulmonary aspergillosis (ABPA) by Menz, G, Hense, G, Willer, G

    Published in Pneumologie (Stuttgart, Germany) (01-07-2003)
    “…Allergic bronchopulmonary aspergillosis (ABPA) is the most common allergic bronchopulmonary mycosis in humans. The diagnosis of the complex disease is based on…”
    Get more information
    Journal Article
  9. 9

    Glucocorticoids upregulate F0XP3 expression and regulatory T cells in asthma by Karagiannidis, C, Akdis, M, Holopainen, P, Woolley, N J, Hense, G, Rueckert, B, Mantel, P-Y, Menz, G, Akdis, CA, Blaser, K, Schmidt-Weber, C B

    Published in Journal of Allergy and Clinical Immunology (01-12-2004)
    “…Background T regulatory (T sub(reg)) cells are characterized by expression of suppressive cytokines and the transcription factor FOXP3. They play a key role in…”
    Get full text
    Journal Article
  10. 10

    Adenosine Receptor A2a is Differentially Expressed in CD4+ T Lymphocytes of Asthmatic and Healthy Individuals by Holopainen, P., Karagiannidis, C., Rückert, B., Hense, G., Schmidt‐Weber, C., Blaser, K.

    Published in Scandinavian journal of immunology (01-06-2004)
    “…The endogenous nucleoside adenosine is released in excess during inflammation or other metabolic stress and is generally known to deliver tissue protective…”
    Get full text
    Journal Article
  11. 11

    Sub-Picosecond Switching of a Semiconductor Microlaser Using Hot-Carrier Effects: Influence of Transverse Effects by Mücke, O. D., Elsässer, M., Hense, S. G., Wegener, M.

    Published in physica status solidi (b) (01-11-1997)
    “…Recently it has been shown experimentally that transient carrier heating and subsequent cooling can be used to switch the emission of a semiconductor vertical…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16

    Schwieriges Asthma by Menz, G, Hense, G

    Published in Pneumologe (01-09-2004)
    “…Schwieriges Asthma lässt sich definieren als Asthma, das sich trotz einer leitliniengerechten Therapie nicht ausreichend kontrollieren lässt. Viele assoziierte…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19
  20. 20